Researchers from New York City-based Montefiore Medical Center and New York City-based Yeshiva University’s Albert Einstein College of Medicine treated C. diff patients with either high or low doses of oral vacomycin every six hours for 72 hours.
After 72 hours, both patient groups showed similar rates of improvement, around 85 percent.
The study results have the potential to change the way antibiotic treatment is approached for C. diff infections, according to the report.
More Articles on Quality:
Curtailing Antibiotic Use Reduces Costs, Complications for Pediatric Inpatients
Music Lowers Distress in Pediatric ED Patients Undergoing Procedures, Study Finds
Information Campaigns May Reduce Unnecessary Antibiotic Use
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
